Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women

NCT06021951 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Lactating Women

Interventions

DRUG: Bempedoic Acid 180 MG Oral Tablet
DRUG: Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral Tablet

Sponsor

Esperion Therapeutics, Inc.